Biodiscovery has announced many leading cancer-research centres have renewed or expanded their licences for the Nexus Copy Number product.
These include renewal of multi-user licence at the Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer, renewal and expansion at the City of Hope Comprehensive Cancer Center, and renewal and expansion at the National Cancer Institute.
Nexus Copy Number detects copy-number aberrations from aCGH and SNP arrays and allows statistical analysis of large cohorts of samples.
One of its largest groups of users and early adopters has been the cancer-research community.
Nexus Copy Number allows different algorithms and custom annotation tracks and can process thousands of arrays from any manufacturer in one project.
